In this review:
Secukinumab for GCA
COVID-19 infection post-vaccination among immunocompromised patients
Heterologous vs homologous booster vaccination in immunosuppressed patients
Patient perceptions of telemedicine in rheumatology during COVID-19
Medication tapering in RA patients in sustained remission
Resistance of RA patients to changing therapy
Treatment experience, patient preferences and disease burden in PsA
All-cause mortality in a hospital cohort with GCA
Non-surgical therapies for hand osteoarthritis
Tapering background therapies during transition to rilonacept monotherapy
Please login below to download this issue (PDF)